← Research library

Mechanisms of the therapeutic effect of Bemitil in neuromuscular diseases

Observational study · 1991

What was studied
21 patients with neuromuscular diseases
Main finding
Examined lipid peroxidation and erythrocyte-membrane permeability during Bemitil treatment.

Reported findings and study design

21 patients with neuromuscular diseases; lipid peroxidation and erythrocyte membrane permeability measured.

Population or model 21 patients with neuromuscular diseases

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Metabolic and membrane measurementsChanges reportedMagnitude, dose and comparator results not quantified in the abstract

Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Clinical-trial indexing does not establish randomization or a concurrent control.
  • Biochemical changes do not establish durable functional improvement.
  • Possible cohort overlap with the 1992 report needs full-text checking.

Source details

Indexed citation and abstract checked; full methods and risk of bias remain unreviewed.

Sources checked

Citation

Uncontrolled human reportEnglish abstract

V. S. Lobzin, L. A. Saikova, M. L. Chukhlovina, V. G. Pustozerov. Mechanisms of the therapeutic effect of Bemitil in neuromuscular diseases Zh Nevropatol Psikhiatr Im S S Korsakova. 91(9):22–24. PMID 1664607

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards